Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - CASH & EQUIVALENTS
Cash & Equivalents NBIX - Neurocrine Biosciences, Inc.
233 M
LAST VALUE
-5.86%
2 YEAR CAGR
15.72%
5 YEAR CAGR
22.34%
10 YEAR CAGR